Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
批准号:
7877712
负责人:
Xinmin Simon Xie
金额:
$32.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-18 至 2012-03-30
关键词:
Absence of pain sensationAdaptive BehaviorsAffectAgonistAnimalsAnti-Anxiety AgentsAnxietyArousalAttentionAttenuatedBehaviorBiological ProcessBoxingBrainComplexConflict (Psychology)CouplingDepressed moodEatingElectronsEquilibriumExhibitsFiberFoodFrightHypothalamic structureImageImmunohistochemistryIn Situ HybridizationInvestigationIon ChannelKnockout MiceLabelLateralLeadLinkMJD1 proteinMediatingMicroinjectionsModelingMotor ActivityMusNaloxoneNerve DegenerationNeuraxisNeuronsNeuropeptidesNociceptionOpiatesOpioid PeptidePainPathway interactionsPeptidesPeripheralPhysiologicalPlayProcessResearchResearch Project GrantsRoleSecond Messenger SystemsSiteSliceSourceSpecificityStressSystemTechniquesTestingWakefulnessalertnessbasebiological adaptation to stressconditioned feardefense responsedrinkingenhanced green fluorescent proteinfollow-uphypocretininsightmelanin-concentrating hormonenerve supplyneurobehaviornociceptinnon-opioid analgesicorexin Apatch clamppostsynapticprepro-orexinpresynapticpreventreceptorresponserestraintrestraint stresssecond messengertransmission processvigilance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nociceptin/orphanin FQ (N/OFQ), via its receptor NOP, modulates nociception, stress, and anxiety. N/OFQ is regarded as an anti-opiate peptide because central N/OFQ causes pronociception and reversal of stress- induced analgesia (SIA). However, N/OFQ can affect nonopioid-mediated analgesia, and its anxiolytic effect is unlikely to be mediated through interaction with the opiate system. Both N/OFQ and NOP are abundant in the hypothalamus, where hypocretins/orexins (Hcrts) are selectively synthesized. The Hcrts regulate wakefulness and alertness, modulate nociceptive processing, and contribute to SIA. Because N/OFQ and Hcrts produce opposite modulations for most behaviors and cellular actions assessed, we hypothesize that N/OFQ exerts its effects on neurobehavior, primarily SIA and fear or stress-induced anxiety-like behavior, through direct modulation of Hcrt neuronal activity in the lateral hypothalamus (LH) and/or interaction at the projected sites that receive both N/OFQ and Hcrt inputs and co-express their cognate receptors. Our preliminary studies show that N/OFQ-containing fibers contact Hcrt neurons and that N/OFQ inhibits Hcrt neuronal activity via both pre- and postsynaptic mechanisms. N/OFQ also depresses cytoplasmic Ca2+ in a majority of the Hcrt neurons in orexin/cameleon 2.1 mouse hypothalamic slices. We found that orexin/ataxin-3 neurodegenerative (orexin/ataxin-3) mice exhibit no SIA in the restraint model. Conversely, intracerebroventricular (icv) administration of Hcrt mimicked SIA in orexin/ataxin-3 mice animals but prevented SIA in wildtype (WT) mice. Furthermore, exogenous Hcrt restored SIA in animals treated with centrally administered N/OFQ. These preliminary results support our hypothesis and lead us to propose the following Specific Aims: 1. Test the hypothesis that N/OFQ-containing fibers contact Hcrt neurons and determine the anatomical source(s) of N/OFQ innervation by using standard anatomical techniques (e.g., immunohistochemistry, in situ hybridization, and retrograde tracing). We will use using multiple labeling quantitative electron microscopical (EM) techniques to further determine whether N/OFQ-containing fibers synaptically contact Hcrt neurons. 2. Characterize the cellular physiological modulation of N/OFQ on Hcrt neurons by using patch clamp recordings of Hcrt neurons from orexin/EGFP mice and by Ca2+ imaging using orexin/cameleon 2.1 mice. 3. Test the hypothesis that N/OFQ blocks SIA partly through the modulation of the Hcrt system by investigating N/OFQ effects on nociceptive processing in WT and orexin/ataxin-3 mice. 4. Test the hypothesis that N/OFQ exerts anxiolytic-like effects partly via inhibition of the Hcrt-mediated stress and anxiety responses in mice using both conditioned and unconditioned fear paradigms. The proposed research will reveal whether there is an integrated neuronal circuit linking the N/OFQ and Hcrt systems that provides a dual-modulation to balance stress responses particularly related to nociceptive processing and stress adaptation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
-
批准号:10760089
-
项目类别:
-
资助金额:$149.99万
-
财政年份:2023
-
负责人:Xinmin Simon Xie
-
依托单位:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
-
批准号:10786151
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2023
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
-
批准号:10815882
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2023
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
-
批准号:8779431
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
-
批准号:9136310
-
项目类别:
-
资助金额:$69.05万
-
财政年份:2014
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
-
批准号:9143175
-
项目类别:
-
资助金额:$74.17万
-
财政年份:2014
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
-
批准号:9442675
-
项目类别:
-
资助金额:$96.07万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
-
批准号:9744038
-
项目类别:
-
资助金额:$24.09万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of Novel Tricyclic Pyrone Drugs for Treatment of Alzheimer Disease
-
批准号:8516617
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of Novel Tricyclic Pyrone Drugs for Treatment of Alzheimer Disease
-
批准号:8681291
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
-
批准号:9348491
-
项目类别:
-
资助金额:$97.31万
-
财政年份:2013
-
负责人:Xinmin Simon Xie
-
依托单位:
Development of automated neurobehavioral assay for rodent stroke model assessment
-
批准号:8058543
-
项目类别:
-
资助金额:$25.31万
-
财政年份:2011
-
负责人:Xinmin Simon Xie
-
依托单位:
Retrograde Tracers with Suicide Enzyme?Prodrug to Study Specific Neural Circuits
-
批准号:7671675
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2009
-
负责人:Xinmin Simon Xie
-
依托单位:
Treat Neuropathic Pain with Dissolvable Microneedles Containing Anti-CGRP Peptide
-
批准号:8538916
-
项目类别:
-
资助金额:$48.92万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
-
批准号:7641103
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
-
批准号:8112192
-
项目类别:
-
资助金额:$2.18万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Microneedle patches deliver a CGRP antagonist for neurogenic inflammatory pain
-
批准号:7329221
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Treat Neuropathic Pain with Dissolvable Microneedles Containing Anti-CGRP Peptide
-
批准号:8454332
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
-
批准号:8117803
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2008
-
负责人:Xinmin Simon Xie
-
依托单位:
Automated Touchscreen-Piezo Monitoring of Mouse Cognition, Activity and Sleep
-
批准号:7272644
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2007
-
负责人:Xinmin Simon Xie
-
依托单位:
海外基金